PreciseART™ Adaptive Radiation Therapy Software makes adaptive radiotherapy simple and practical for every practice. This software enables clinicians to monitor every patient and efficiently adapt plans, helping clinics of all sizes deliver more precise treatments to more patients
The PreciseRTX™ Retreatment Option accelerates and automates the re-planning process to make re-treatment more efficient for practices and more effective for patients in those cases where, unfortunately, cancer has recurred and additional radiation treatments are necessary
The system is pre-commissioned and only needs to be verified by the customer. This speeds the overall process, with time to first treatment proven to typically take only two weeks from the start of installation
A wide range of cancer indications can be treated


The Radixact® System can be used for virtually any case for which radiation therapy is prescribed, including:
Large tumors or multiple tumors throughout the body
Standard radiation therapy indications such as breast, lung, prostate, and head and neck cancers
Complex treatments such as total marrow irradiation and whole-brain with simultaneous boosts to multiple metastases
The system precisely targets cancer cells, enabling doctors to effectively treat:
Hard-to-reach tumors
Tumors that have recurred, including those in patients who may not be candidates for retreatment with traditional delivery systems


About Accuray
Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.


SOURCE Accuray Incorporated

Back to HCB News

Rad Oncology Homepage